Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions

BMC Pharmacology

Volumn 5, Issue , 2005, Pages

  Angelico, Patrizia ^a   Velasco, Cristina ^a   Guarneri, Luciano ^a   Sironi, Giorgio ^a   Leonardi, Amedeo ^a   Testa, Rodolfo ^a  

^a Recordati SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN; TOLTERODINE; BENZHYDRYL DERIVATIVE; CRESOL; MANDELIC ACID DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CAPACITY; BLADDER CONTRACTION; CONSCIOUSNESS; CONTROLLED STUDY; CYSTOMETRY; DOSE RESPONSE; DRUG MECHANISM; DRUG RESPONSE; MICTURITION; NONHUMAN; RAT; RECEPTOR BLOCKING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; URODYNAMICS; ANIMAL; BLADDER; BLADDER CATHETERIZATION; DRUG EFFECT; MALE; URINE INCONTINENCE;

ANIMALS; BENZHYDRYL COMPOUNDS; CRESOLS; MALE; MANDELIC ACIDS; MUSCARINIC ANTAGONISTS; PHENYLPROPANOLAMINE; RATS; URINARY BLADDER; URINARY CATHETERIZATION; URINARY INCONTINENCE; URINATION;

EID: 27644487502     PISSN: 14712210     EISSN: 14712210     Source Type: Journal    
DOI: 10.1186/1471-2210-5-14     Document Type: Article

References (40)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A: The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002, 21: 167-178.
2. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ: How widespread are the symptoms of an over active bladder and how are they managed ? A population-based prevalence study. BJU Int 2001, 87: 760-766.
3. Wein AJ, Rovner ES: The overactive bladder: an over view for primary care health providers. Int J Fertil 1999, 44: 56-66.
4. Brading AF: A myogenic basis for the overacting bladder. Urology 1997, 50 (Suppl. 6A): 57-67.
5. De Groat WC: A neurologic basis for the overactive bladder. Urology 1997, 50 (Suppl. 6A): 36-52.
6. Yoshimura N, Chancellor MB: Current and future pharmacological treatment for over active bladder. J Urol 2002, 168: 1897-1913.
7. Chapple RC: Muscarinic receptor antagonists in the treatment of overactive bladder. Urology 2000, 55 (Suppl. 5A): 33-46.
8. Yarker YE, Goa KL, Fitton A: Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs & Aging 1995, 6: 243-262.
9. Guarneri L, Cova R, Angelico P, Colli E, Testa R: Effects of different drugs on the cystometrogram in conscious rats. Pharmacol Res 1991, 24: 175-187.
10. Guarneri L, Ibba M, Angelico P, Testa R: Effects of oxybutynin, terodiline and nifedipine on the cystometrogram in conscious rats with infra vesical outflow obstruction. Pharmacol Res 1991, 24: 263-272.
11. Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M: Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol 1995, 154: 2174-2178.
12. Yokoyama O, Ishiura Y, Nakamura Y, Ohkawa M: Urodynamic effects of intravesical oxybutynin chloride in conscious rats. J Urol 1996, 155: 768-771.
13. Williamson IJR, Newgreen DT, Naylor AM: The effects of darifenacin and oxybutynin on bladder function and salivation in the conscious rat. Br J Pharmacol 1997, 120: 205P.
14. Kwak TI, Lee JG: Inhibitory effects of propiverine, atropine and oxybutynin on bladder instability in rats with infravesical outlet obstruction. BJU 1998, 82: 272-277.
15. Velasco C, Guarneri L, Leonardi A, Testa R: Influence of pump compliance (peristaltic vs. infusion) on urodynamic measurement during cystometry in conscious rats. J Pharmacol Toxicol Methods 2001, 45: 215-21.
16. Modiri AR, Alberts P, Gillberg PG: Effect of muscarinic antagonists on micturition pressure measured by cystometry in normal, conscious rats. Urology 2002, 59: 963-968.
17. Ishizuka O, Gu BJ, Yang ZX, Nishizawa O, Andersson K-E: Functional role of central muscarinic receptors for micturition in normal conscious rats. J Urol 2002, 168: 2258-2262.
18. Shimizu I, Kawashima K, Ishii D, Oka M: Urodynamics in a rat neurogenic bladder model with a unilateral electrolytic lesion of the basal forebrain. BJU Int 2003, 91: 861-867.
19. Morrison J, Steers WD, Brading A, Blok B, Fry C, De Groat WC, Kakizaki H, Levin R, Thor K: Neurophysiology and neuropharmacology. In P Abrams, L Cardozo, S Khoury and A Wein eds, Incontinence 2nd edn, Plymouth, United Kingdom: Plymbridge Distributors Ltd., 2002: 85-163.
20. Igawa Y, Mattianson A, Andersson K-E: Functional importance of cholinergic and purinergic neuro-transmission for micturition contraction in the normal, unanesthetized rat. Br J Pharmacol 1993, 109: 473-479.
21. Testa R, Angelico P, Velasco C, Guarneri L, Leonardi A: Urodynamic effects of oral oxybutynin in conscious rats under different cystometrographic conditions. 33rd International Continence Society Annual Meeting, Florence, 2003, Abs. 316.
22. Maggi CA, Evangelista S, Grimaldi G, Santicioli P, Giolitti A, Meli A: Evidence for the involvement of arachidonic acid metabolites in spontaneous and drug-induced contractions of rat urinary bladder. J Pharmacol Exp Ther 1984, 230: 500-513.
23. Maggi CA, Santicioli P, Furio M, Meli A: The effect of cyclooxygenase inhibitors on the low filling rate cystometrogram in urethane anesthetized rats. J Urol 1985, 134: 800-803.
24. Maggi CA, Giuliani S, Patacchini R, Conte B, Furio M, Santicioli P, Meli P, Gragnani L, Meli A: The effect of SC-19220, a prostaglandin antagonist, on the micturition reflex in rats. Eur J Pharmacol 1988, 152: 273-279.
25. Maggi CA: Prostanoids as local modulators of reflex micturition. Pharmacol Res 1992, 25: 13-20.
26. Yaksh TL, Durant PAC, Brent CR: Micturition in rats: a chronic model for study of bladder function on effect of anesthetics. Am J Physiol 1986, 251: R1177-R1185.
27. Morikawa K, Hichihashi M, Kakiuchi M, Yamauchi T, Kato H, Ito Y, Gomi Y: Effects of various drugs on bladder function in conscious rats. Japan J Pharmacol 1989, 50: 369-376.
28. Ferguson DR, Kennedy I, Burton TJ: ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism? J Physiol 1997, 505: 503-511.
29. Pandita RK, Andersson K.-E. Intravesical adenosine triphosphate stimulates the micturition reflex in awake, freely moving rats. J Urol 2002, 168: 1230-1234.
30. Cova R, Guarneri L, Angelico P, Velasco C, Leonardi A, Testa R: Effects of infravescical suramin and PPADS on cystometrographic parameters in conscious rats. Urodinamica 1999, 9: 162-168.
31. Fabiyi AC, Gopalakrishnan M, Lynch JJ, Brioni JD, Coghlan MJ, Brune ME: In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel opener (-)-cromakalim, ZD6169 and WAY-133537 in rats. BJU Int 2003, 91: 284-290.
32. Andersson K-E: Potential benefits of muscarinic M3 receptor selectivity. Eur Urol 2002, Suppl. 1: 23-28.
33. Masuda H, Tsujii T, Azuma H, Oshima H: Role of a central muscarinic cholinergic pathway for relaxation of the proximal urethra during the voiding phase in rats. J Urol 2001, 165: 999-1003.
34. Yokoyama O, Ootsuka N, Komatsu K, Kodama K, Yotsuyanagi S, Niikura S, Nagasaka Y, Nakada Y, Kanie S, Namiki M: Forebrain muscarinic control of micturition reflex in rats. Neuropharmacol 2001, 41: 629-638.
35. Ogasawara M Shimoda N, Sato K, Kato T, Sugaya K: The effects of the antagonists of muscarinic acetylcholine receptor subtypes in rat brain on urinary bladder contraction. Nippon Hinyokika Gakki Zasshi 2002, 93: 427-434.
36. Ishiura Y, Yoshiyama M, Yokoyama O, Namiki M, De Groat WC: Central muscarinic mechanism regulating voiding in rats. J Pharmacol Exp Ther 2001, 297: 933-939.
37. Andersson K-E, Yoshida M: Antimuscarinics and the overactive detrusor-which is the main mechanism of action ? Eur Urol 2003, 43: 1-5.
38. Kim Y, Yoshimura N, Masuda, H, de Miguel F, Chancellor MB: Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways. Urology 2005, 65: 238-242.
39. Kawabe K, Abe S, Kanda T, Tei K. Clinical reevaluation of the effect of oxybutynin chloride on unhinibited neurogenic and reflex neurogenic bladder. Urol Int 1986, 41: 16-20.
40. Stahl MMS, Ekstrom B, Sparf B, Mattiasson A, Andersson K-E: Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity. Neurourol Urodyn 1995, 14: 647-655.